Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: ImmunityBio Inc., 3 years.
ImmunityBio Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
ImmunityBio Inc. June 9, 202698.5%
-
ImmunityBio Inc. June 18, 202599.6%
-
ImmunityBio Inc. June 11, 202499.8%
-
ImmunityBio Inc. June 13, 202399.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2026 | ImmunityBio Inc. | Option exercise | +35,064 | $2.98 | $104,491 |
| Jul 1, 2026 | ImmunityBio Inc. | Option exercise | +124,414 | $2.99 | $371,998 |
| Jul 1, 2026 | ImmunityBio Inc. | Open-market sale | −159,478 | $9.02 | $1,439,066 |
| Jun 30, 2026 | ImmunityBio Inc. | Option exercise | +700 | $2.98 | $2,086 |
| Jun 30, 2026 | ImmunityBio Inc. | Option exercise | +300 | $2.99 | $897 |
| Jun 30, 2026 | ImmunityBio Inc. | Open-market sale | −1,000 | $9.00 | $9,000 |
| Jun 29, 2026 | ImmunityBio Inc. | Option exercise | +32,173 | $2.98 | $95,876 |
| Jun 29, 2026 | ImmunityBio Inc. | Option exercise | +33,549 | $2.99 | $100,312 |
| Jun 29, 2026 | ImmunityBio Inc. | Option exercise | +30,000 | $2.84 | $85,200 |
| Jun 29, 2026 | ImmunityBio Inc. | Open-market sale | −95,722 | $9.01 | $862,216 |
| Feb 23, 2026 | ImmunityBio Inc. | Option exercise | +25,000 | $2.98 | $74,500 |
| Feb 23, 2026 | ImmunityBio Inc. | Open-market sale | −25,000 | $10.00 | $250,000 |
| Jan 20, 2026 | ImmunityBio Inc. | Option exercise | +25,000 | $2.98 | $74,500 |
| Jan 20, 2026 | ImmunityBio Inc. | Open-market sale | −25,000 | $7.51 | $187,750 |
| Jan 16, 2026 | ImmunityBio Inc. | Option exercise | +50,000 | $2.98 | $149,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.